Roivant Sciences annual debt-to-equity ratio
2020
2021
2022
2023
2024
2025
Roivant Sciences Debt-to-Equity Ratio Growth & History (ROIV)
Roivant Sciences's debt-to-equity ratio was 0.02 for fiscal 2025.
View full Roivant Sciences company overviewRoivant Sciences annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2026-03-31 | 0.02 | 0.00 | +11.05% |
| 2024 | 2025-03-31 | 0.02 | −0.06 | −73.85% |
| 2023 | 2024-03-31 | 0.08 | −0.30 | −78.80% |
| 2022 | 2023-03-31 | 0.39 | 0.21 | +125.01% |
| 2021 | 2022-03-31 | 0.17 | 0.04 | +25.74% |
| 2020 | 2021-03-31 | 0.14 | — | — |
Roivant Sciences quarterly debt-to-equity ratio
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-06-30 | 0.03 | 0.00 | +10.39% |
| Q4 2025 | 2026-03-31 | 0.02 | 0.00 | +11.05% |
| Q3 2025 | 2025-12-31 | 0.03 | 0.01 | +32.01% |
| Q2 2025 | 2025-09-30 | 0.02 | 0.01 | +121.52% |
| Q1 2025 | 2025-06-30 | 0.02 | −0.04 | −66.03% |
| Q4 2024 | 2025-03-31 | 0.02 | −0.06 | −73.85% |
| Q3 2024 | 2024-12-31 | 0.02 | −0.06 | −74.46% |
| Q2 2024 | 2024-09-30 | 0.01 | −0.46 | −97.84% |
| Q1 2024 | 2024-06-30 | 0.07 | −0.42 | −86.28% |
| Q4 2023 | 2024-03-31 | 0.08 | −0.30 | −78.80% |
| Q3 2023 | 2023-12-31 | 0.08 | −0.39 | −83.64% |
| Q2 2023 | 2023-09-30 | 0.47 | 0.09 | +24.42% |
| Q1 2023 | 2023-06-30 | 0.49 | 0.14 | +39.23% |
| Q4 2022 | 2023-03-31 | 0.39 | 0.21 | +125.01% |
| Q3 2022 | 2022-12-31 | 0.46 | 0.31 | +211.08% |
| Q2 2022 | 2022-09-30 | 0.38 | 0.24 | +180.31% |
| Q1 2022 | 2022-06-30 | 0.35 | 0.20 | +131.02% |
| Q4 2021 | 2022-03-31 | 0.17 | 0.04 | +25.74% |
| Q3 2021 | 2021-12-31 | 0.15 | — | — |
| Q2 2021 | 2021-09-30 | 0.14 | — | — |
| Q1 2021 | 2021-06-30 | 0.15 | — | — |
| Q4 2020 | 2021-03-31 | 0.14 | — | — |
Roivant Sciences debt-to-equity ratio trends
Over the last five fiscal years, Roivant Sciences's debt-to-equity ratio decreased from 0.14 to 0.02, a change of −0.11. The latest reported quarter, Q1 2026, shows 0.03.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Roivant Sciences source filings ↗